Dr. S(@asoltani8) 's Twitter Profile Photo

Recent thrombectomy market dynamics. From Guidepoint surveys. Market growing as a whole, $NARI losing some share to $PEN. $BSX and $ANGO marginal players.

Recent thrombectomy market dynamics. From Guidepoint surveys. Market growing as a whole, $NARI losing some share to $PEN. $BSX and $ANGO marginal players.
account_circle
Amrou Sarraj(@amrsarrajMD) 's Twitter Profile Photo

Thank you Medscape Indeed, TESLA Stroke Trial results are in the same direction. It’s the totally of evidence that we should evaluate. Looking forward to TENSION Study & LASTE results to update MAGNA and provide the field with the highest level of evidence
medscape.com/viewarticle/99…

account_circle
Henning(@researchbyh) 's Twitter Profile Photo

Recent product launch from $PEN seems to rather expand the market than stealing market share from others. $NARI grew 8% sequentially while losing market share due to the market expansion. Inari trading weakly due to Penumbra fear feels unmotivated.
qsight.guidepoint.com/lightning-stri…

account_circle
C. Michael Gibson MD(@CMichaelGibson) 's Twitter Profile Photo

3/ , presented at by Mitch Silver, was a non-randomized study with a pre-specified
performance goal evaluating outcomes in high-risk PE patients treated with large-bore
thrombectomy (n=53) & other contemporary treatments (n=61)

3/ #FLAME, presented at #ACC23 by Mitch Silver, was a non-randomized study with a pre-specified
performance goal evaluating outcomes in high-risk PE patients treated with #FlowTriever large-bore
thrombectomy (n=53) & other contemporary treatments (n=61)
account_circle
Artur Dziadkiewicz(@ArturBrain) 's Twitter Profile Photo

Tandem occlusion in posterior circulation - RVA prox. occl. on atherosclerotic stenosis and BA distal occl. ADAPT in BA (1pass with TICI3-LPCA connected with anter.circul.) then ballon-expand.stent in RVA Szpitale Pomorskie

Tandem occlusion in posterior circulation - RVA prox. occl. on atherosclerotic stenosis and BA distal occl. ADAPT in BA (1pass with TICI3-LPCA connected with anter.circul.) then ballon-expand.stent in RVA @SzpitaleP #neurotwitter #thrombectomy #stroke #posteriorcirculaton #BAO
account_circle
Robert Ford, MD(@RobertFordMD) 's Twitter Profile Photo

Mixed chronicity portomesenteric thrombosis, transjugular transhepatic Inari Medical FlowTriever T16 thrombectomy, excellent technical/clinical results! FT2 essential to engage more chronic components - interested to hear opinions thrombectomy vs thrombolysis in this space …

Mixed chronicity portomesenteric thrombosis, transjugular transhepatic @InariMedical FlowTriever T16 thrombectomy, excellent technical/clinical results! FT2 essential to engage more chronic components - interested to hear opinions thrombectomy vs thrombolysis in this space …
account_circle
Inari Medical(@InariMedical) 's Twitter Profile Photo

A first for stent thrombosis, the RevCore™ catheter’s user-controlled element is uniquely designed to remove the full range of chronicity. Come check out this week during at booth 703!

See you there!

A first for #venous stent thrombosis, the RevCore™ #Thrombectomy catheter’s user-controlled element is uniquely designed to remove the full range of #clot chronicity. Come check out #RevCore this week during #VAM23 at booth 703!

See you there!
account_circle
Pouria Moshayedi, MD PhD(@PouriaMoshayedi) 's Twitter Profile Photo

How early do you trach debilitated stroke patients?

pubmed.ncbi.nlm.nih.gov/37336143/

An excellent retrospective analysis, showing trach before day 8 is associated with earlier discharge, less pneumonia/sepsis/AKI, but no mortality benefit.

Stroke Trials Fawaz Al-Mufti, MD, FSVIN Get Ahead of Stroke

account_circle
AshuJadhav(@AshuPJadhav) 's Twitter Profile Photo

Impact of vessel tortuosity and radiological thrombus characteristics on the choice of first-line thrombectomy strategy: Results from the ESCAPE-NA1 trial journals.sagepub.com/doi/full/10.11…

Impact of vessel tortuosity and radiological thrombus characteristics on the choice of first-line thrombectomy strategy: Results from the ESCAPE-NA1 trial journals.sagepub.com/doi/full/10.11…
account_circle
Surmodics, Inc.(@Surmodics) 's Twitter Profile Photo

That's a wrap ! The Pounce™ Thrombectomy System is redefining arterial thrombectomy—with no capital equipment. The NEW Sublime™ Microcatheter is designed to provide the torque, kink resistance & push needed to cross tough lesions from any access site. Rx only.

account_circle
AshuJadhav(@AshuPJadhav) 's Twitter Profile Photo

Real-World Outcomes for Basilar Artery Occlusion Thrombectomy With Mild Deficits: The National Inpatient Sample | Stroke ahajournals.org/doi/10.1161/ST…

Real-World Outcomes for Basilar Artery Occlusion Thrombectomy With Mild Deficits: The National Inpatient Sample | Stroke ahajournals.org/doi/10.1161/ST…
account_circle
Renal Interventions(@Renal_Ints) 's Twitter Profile Photo

.Ounali Jaffer talks through thrombectomy devices being used in other vascular beds to examine whether they might offer options in the AV space. Penumbra Cat D, Abbott’s Jeti (formerly Walk Vascular), Inari’s in Thrill device and Pounce venous thrombectomy get a mention. EVA Meeting

.@OJaffer2 talks through thrombectomy devices being used in other vascular beds to examine whether they might offer options in the AV space. Penumbra Cat D, Abbott’s Jeti (formerly Walk Vascular), Inari’s in Thrill device and Pounce venous thrombectomy get a mention. @evameeting
account_circle